Pfizer reported second-quarter earnings that beat analysts’ estimates and raised its full-year profit forecast as sales of a new cancer drug climbed. Bloomberg's Cynthia Koons also reports on Merck's performance on "Market Makers."
ENJOY GREECE
We Explore, Find, Check & Propose You for the Truth - Enjoy GREECE - Enjoy EUROPE - Enjoy WORLD
